Description

Benzo[F]Quinazolin-3(2H)-One, 1,4,5,6-Tetrahydro- (9Ci) is a specialized heterocyclic organic compound belonging to the quinazolinone class, serving as a crucial advanced intermediate in modern synthetic chemistry. Its value lies in its complex fused-ring structure, which makes it a versatile building block for constructing more elaborate molecular architectures. This compound is primarily needed by research institutions and pharmaceutical companies engaged in the development of novel active pharmaceutical ingredients (APIs), agrochemicals, and functional materials.

Application

• Pharmaceutical Intermediate: A key synthon in the research and development of potential drug candidates, particularly for central nervous system (CNS) agents, anti-cancer compounds, and kinase inhibitors.
• Agrochemical Research: Used as a core scaffold for synthesizing novel herbicides, fungicides, and insecticides with enhanced efficacy and selectivity.
• Material Science Precursor: Serves as a starting material for creating organic semiconductors, light-emitting diodes (OLEDs), and other advanced functional materials due to its conjugated system.
• Chemical Biology Probe Development: Employed in the synthesis of molecular probes and tool compounds for studying biological pathways and target validation.
• Academic & Contract Research: Essential for methodological studies in organic synthesis, including novel cyclization and functionalization reactions.
• Custom Synthesis & Scale-Up: A critical intermediate for custom manufacturing organizations (CMOs) scaling up processes from laboratory to pilot plant and commercial production.

Basic Information

Product Name	Benzo[F]Quinazolin-3(2H)-One, 1,4,5,6-Tetrahydro- (9Ci)
CAS No.	594823-59-3
Molecular Formula	C₁₂H₁₂N₂O
Molecular Weight	200.24 g/mol
Synonyms	1,4,5,6-Tetrahydrobenzo[f]quinazolin-3(2H)-one; 2,3,4,5-Tetrahydro-1H-benzo[f]quinazolin-3-one; Benzo[f]quinazolin-3(2H)-one, 1,4,5,6-tetrahydro-; Tetrahydrobenzo[f]quinazolin-3-one; BQTO intermediate; Quinazolinone derivative CAS 594823-59-3
EINECS	Contact for details

Quality Control

Every batch of Benzo[F]Quinazolin-3(2H)-One, 1,4,5,6-Tetrahydro- (9Ci) undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our quality management system is designed to meet the stringent requirements of research and pre-clinical development. A comprehensive Certificate of Analysis (COA) detailing purity (typically by HPLC), identity confirmation (by IR, NMR), and impurity profile is provided with each shipment to support your regulatory and R&D documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed when not in use to protect against moisture absorption and contamination. Observe standard laboratory safety practices for handling fine chemical powders.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.